Abstract Polycystic ovarian syndrome (PCOS) is an endocrinological condition that leads to infertility in many females
It slows gastric emptying, increases insulin secretion in response to meals, and decreases glucagon releasecollectively lowering postprandial and fasting glucose levels
The search terms used were glucagon-like peptide 1 receptor agonist, exenatide, liraglutide, dulaglutide, lixisenatide, semaglutide, albiglutide, taspoglutide, loxenatide, diabetes mellitus, obesity and randomized controlled trial
In one study, about 17% of participants receiving cagrilintide alone reported redness, swelling, or discomfort at the injection sitecompared with about 3% of those receiving semaglutide
As a new medication, it may not be widely available, and the cost may be prohibitive for some patients
It is primarily used in the management of type 2 diabetes mellitus to help improve blood sugar control and promote weight loss